Citadel Advisors - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 19 filers reported holding ATYR PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q1 2019$45,000
+181.2%
80,941
+157.1%
0.00%
Q4 2018$16,000
-54.3%
31,477
-18.7%
0.00%
Q2 2018$35,000
-22.2%
38,734
+201.8%
0.00%
Q4 2017$45,000
-76.9%
12,833
-35.5%
0.00%
Q4 2015$195,00019,8910.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$3,930,0004.66%
EcoR1 Capital, LLC 976,986$2,101,0000.67%
TANG CAPITAL MANAGEMENT LLC 279,425$601,0000.32%
Rock Springs Capital Management LP 475,000$1,021,0000.07%
Quotient Investors, LLC 22,200$48,0000.03%
Alyeska Investment Group, L.P. 1,072,108$2,305,0000.02%
TIVERTON ASSET MANAGEMENT LLC 95,318$205,0000.01%
RIVERHEAD CAPITAL MANAGEMENT LLC 79,677$171,0000.01%
Acrospire Investment Management LLC 12,683$27,0000.01%
Glen Harbor Capital Management LLC 179,724$386,0000.01%
View complete list of ATYR PHARMA INC shareholders